European Journal of Epidemiology

, Volume 25, Issue 6, pp 365–374 | Cite as

Screening for a cancer: thinking before rethinking



A recent article (by Esserman et al.) called to serious question the diagnostic and prognostic premises of screening for breast and prostate cancers, and it proceeded to adduce, also, other radical rethinking of these screenings. That questioning was ‘evidence-based’ in the contemporary epidemiological meaning of this—use was made of cancer-registry data as well as of evidence from such randomized trials as epidemiologists now take to be essential in actual research on screening for a cancer—and, evidence-based as it was, that questioning has been left unquestioned. But that questioning, as to the interpretation of the evidence, was not adequately thinking-based. It was, instead, rife with the misunderstandings that permeate contemporary epidemiological thinking about screening for a cancer and about research for the scientific knowledge-base of this. In the truly called-for rethinking, the point of departure would be the recognition that the premises of screening for a cancer are clinical in nature, as obviously also are both the entire process potentially leading to a cancer’s early, preclinical diagnosis and the individual counselling about submitting oneself to this. Epidemiologists should focus on epidemiology—practice of and research for community medicine, community-level preventive medicine, that is—and to have no presumptions of understanding, better than clinicians, the (clinical) issues surrounding the pursuit of early diagnosis of a cancer, whether matters of practice, research, or public policy. Clinicians and clinical researchers, in turn, should disregard epidemiologists’—and other public-health professionals’—ideas about screening for a cancer, the practice of and research on this. The need for this aprioristic rethinking is manifest, very eminently, in the fresh recommendations about screening for breast cancer, issued by the US Preventive Services Task Force, and in the public uproar provoked by these.


Cancer Evidence-based medicine Overdiagnosis Overtreatment Screening 


  1. 1.
    Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302:1685–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Kolata G. Cancers can vanish without treatment, but how? New York Times, 27 October 2009. Also: The mystery of cancers that vanish. International Herald Tribune, 29 October 2009.Google Scholar
  3. 3.
    Kolata G. Cancer society, in shift, has concerns on screenings. New York Times, 21 October 2009.Google Scholar
  4. 4.
    Beck EM (Ed) Familiar Quotations by John Bartlett. Fourteenth edition, revised and enlarged. Boston: Little, Brown, and Company, 1968.Google Scholar
  5. 5.
    Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992; 2420–5.Google Scholar
  6. 6.
    Miettinen OS. Important concepts in epidemiology. In: Olsen J, Saracci R, Trichopoulos D, editors. Teaching epidemiology. 3rd ed. Oxford: Oxford University Press; 2010.Google Scholar
  7. 7.
    Bacon F. The essays or counsels civil and moral. Oxford: Oxford University Press; 1999. p. 134.Google Scholar
  8. 8.
    Porta M, Greenland S, Last JM, editors. A dictionary of epidemiology. A handbook sponsored by the I.E.A. 5th ed. Oxford: Oxford University Press; 2008.Google Scholar
  9. 9.
    Miettinen OS, Henschke CI, Pasmantier MW, et al. Mammographic screening: no reliable supporting evidence? Lancet. 2002;359:404–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Miettinen OS. Screening for a cancer: a sad chapter in epidemiology. Eur J Epidemiol. 2008;23:647–53.CrossRefPubMedGoogle Scholar
  11. 11.
    U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26.Google Scholar
  12. 12.
    Goldberg P. HHS secretary rebukes Task Force guidelines on breast cancer screening. The Cancer Letter 2009; 35:20 November.
  13. 13.
    Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738–47.PubMedGoogle Scholar
  14. 14.
    Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727–37.PubMedGoogle Scholar
  15. 15.
    von Mises L. Human action. A treatise on economics. 3rd revised ed. Chicago: Contemporary Books Inc.; 1966. p. 10.Google Scholar
  16. 16.
    Pielke RA Jr. The honest broker. Making sense of science in policy and politics. Cambridge: Cambridge University Press; 2007. p. 5.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of Epidemiology, Biostatistics and Occupational HealthMcGill UniversityMontrealCanada
  2. 2.Department of Medicine, Faculty of MedicineMcGill UniversityMontrealCanada
  3. 3.Department of Medicine, Weill Medical CollegeCornell UniversityNew YorkUSA

Personalised recommendations